Bristol-Myers Squibb Company Ce
General ticker "CELG-RI" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $122.0B (TTM average)
Bristol-Myers Squibb Company Ce follows the US Stock Market performance with the rate: 18.9%.
Estimated limits based on current volatility of 16.5%: low 0.11$, high 0.16$
Factors to consider:
- Total employees count: 32500 (-4.7%) as of 2025
- US accounted for 69.1% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Pricing pressure, R&D failure, Regulatory and compliance, Operational and conduct risks, Supply chain disruptions
- Current price 45.4% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.05$, 0.11$]
- 2026-12-31 to 2027-12-31 estimated range: [0.07$, 0.14$]
Short-term CELG-RI quotes
Long-term CELG-RI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $45,006.00MM | $47,407.00MM | $47,520.00MM |
| Operating Expenses | $36,811.00MM | $55,786.00MM | $38,192.00MM |
| Operating Income | $8,195.00MM | $-8,379.00MM | $9,328.00MM |
| Non-Operating Income | $245.00MM | $0.00MM | $0.00MM |
| Interest Expense | $1,166.00MM | $1,947.00MM | $1,891.00MM |
| R&D Expense | $9,299.00MM | $11,159.00MM | $9,951.00MM |
| Income(Loss) | $8,440.00MM | $-8,379.00MM | $9,328.00MM |
| Taxes | $400.00MM | $554.00MM | $2,272.00MM |
| Net Income(Loss)* | $8,025.00MM | $-8,948.00MM | $7,054.00MM |
| Stockholders Equity | $29,430.00MM | $16,335.00MM | $18,473.00MM |
| Inventory | $2,662.00MM | $2,557.00MM | $2,690.00MM |
| Assets | $95,159.00MM | $92,603.00MM | $90,038.00MM |
| Operating Cash Flow | $13,860.00MM | $15,190.00MM | $14,156.00MM |
| Capital expenditure | $1,209.00MM | $1,248.00MM | $1,311.00MM |
| Investing Cash Flow | $-2,295.00MM | $-21,352.00MM | $-4,132.00MM |
| Financing Cash Flow | $-9,416.00MM | $5,127.00MM | $-10,348.00MM |
| Earnings Per Share** | $3.88 | $-4.41 | $3.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.